Page 2 - Pulmatrix Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pulmatrix (PULM) Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine

Pulmatrix (PULM) Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ted raadPulmatrix incCompany nasdaqChief executive officer

Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update

Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesTed raadTimothy mccarthyCompany nasdaqAmerican headache societyExchange commissionPulmatrix incCompany quarterly reports on formChief executive officerRecent programAnnual meetingCipla agreementChronic obstructive pulmonary diseaseAnnual reportQuarterly reportsCurrent reports

Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews com

Equities research analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Pulmatrix Price Performance PULM stock opened at $1.89 on Thursday. Pulmatrix has a 12 month low of $1.55 and a […]

United statesPulmatrix incGet free reportPulmatrix dailyNasdaq pulmInitiated coverageStocknews com

Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews com

Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesPulmatrix incFree reportStock downGet free reportPulmatrix daily

Pulmatrix (NASDAQ:PULM) Research Coverage Started at StockNews com

Stock analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Pulmatrix Price Performance Pulmatrix stock opened at $2.08 on Wednesday. The stock has a market cap of $7.59 million, a price-to-earnings […]

United statesPulmatrix incPulmatrix company profileGet free reportPulmatrix dailyNasdaq pulmInitiated coverageStocknews com